RPRX logo

Royalty Pharma (RPRX) Total debt

Annual Total Debt:

$7.61B+$1.48B(+24.08%)
December 31, 2024

Summary

  • As of today (May 21, 2025), RPRX annual total debt is $7.61 billion, with the most recent change of +$1.48 billion (+24.08%) on December 31, 2024.
  • During the last 3 years, RPRX annual total debt has risen by +$516.36 million (+7.28%).
  • RPRX annual total debt is now at all-time high.

Performance

RPRX Total debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXbalance sheet metrics

Quarterly Total Debt:

$7.62B+$5.03M(+0.07%)
March 31, 2025

Summary

  • As of today (May 21, 2025), RPRX quarterly total debt is $7.62 billion, with the most recent change of +$5.03 million (+0.07%) on March 31, 2025.
  • Over the past year, RPRX quarterly total debt has increased by +$1.48 billion (+24.08%).
  • RPRX quarterly total debt is now at all-time high.

Performance

RPRX Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXbalance sheet metrics

Total debt Formula

Total Debt = Short Term Debt + Long Term Debt

RPRX Total debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+24.1%+24.1%
3 y3 years+7.3%+7.3%
5 y5 years+22.0%+27.9%

RPRX Total debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+24.1%at high+24.2%
5 y5-yearat high+30.9%at high+31.1%
alltimeall timeat high>+9999.0%at high>+9999.0%

RPRX Total debt History

DateAnnualQuarterly
Mar 2025
-
$7.62B(+0.1%)
Dec 2024
$7.61B(+24.1%)
$7.61B(+0.1%)
Sep 2024
-
$7.61B(+0.1%)
Jun 2024
-
$7.60B(+23.8%)
Mar 2024
-
$6.14B(+0.1%)
Dec 2023
$6.14B(-13.8%)
$6.14B(+0.1%)
Sep 2023
-
$6.13B(-14.0%)
Jun 2023
-
$7.13B(+0.1%)
Mar 2023
-
$7.12B(+0.1%)
Dec 2022
$7.12B(+0.3%)
$7.12B(+0.1%)
Sep 2022
-
$7.11B(+0.1%)
Jun 2022
-
$7.11B(+0.1%)
Mar 2022
-
$7.10B(+0.1%)
DateAnnualQuarterly
Dec 2021
$7.10B(+22.0%)
$7.10B(+0.1%)
Sep 2021
-
$7.09B(+21.7%)
Jun 2021
-
$5.83B(+0.1%)
Mar 2021
-
$5.82B(+0.1%)
Dec 2020
$5.82B(-6.8%)
$5.82B(+0.1%)
Sep 2020
-
$5.81B(-1.7%)
Jun 2020
-
$5.91B(-0.8%)
Mar 2020
-
$5.96B(-4.5%)
Dec 2019
$6.24B(-4.3%)
$6.24B(>+9900.0%)
Sep 2019
-
$0.00(0.0%)
Jun 2019
-
$0.00(0.0%)
Mar 2019
-
$0.00
Dec 2018
$6.52B(>+9900.0%)
-
Dec 2017
$0.00
-

FAQ

  • What is Royalty Pharma annual total debt?
  • What is the all time high annual total debt for Royalty Pharma?
  • What is Royalty Pharma annual total debt year-on-year change?
  • What is Royalty Pharma quarterly total debt?
  • What is the all time high quarterly total debt for Royalty Pharma?
  • What is Royalty Pharma quarterly total debt year-on-year change?

What is Royalty Pharma annual total debt?

The current annual total debt of RPRX is $7.61B

What is the all time high annual total debt for Royalty Pharma?

Royalty Pharma all-time high annual total debt is $7.61B

What is Royalty Pharma annual total debt year-on-year change?

Over the past year, RPRX annual total debt has changed by +$1.48B (+24.08%)

What is Royalty Pharma quarterly total debt?

The current quarterly total debt of RPRX is $7.62B

What is the all time high quarterly total debt for Royalty Pharma?

Royalty Pharma all-time high quarterly total debt is $7.62B

What is Royalty Pharma quarterly total debt year-on-year change?

Over the past year, RPRX quarterly total debt has changed by +$1.48B (+24.08%)
On this page